What You Should Know:
- Trinity Life Sciences, a leader in global life sciences commercialization solutions, has released a new white paper titled "Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA's Latest Guidance."
- The paper sheds light on the critical issue of racial and ethnic diversity in clinical trials, exploring current industry initiatives, their effectiveness, and the future landscape shaped by the FDA's evolving
Read More
eVisit Acquires UPMC’s Inpatient Teleconsult Technology
What You Should Know:
- eVisit, a provider of virtual care solutions for health systems, announced a significant expansion today through a three-pronged approach: acquisition of UPMC's inpatient teleconsult technology, strategic investments from UPMC Enterprises and MedStar Health, and the addition of key figures to its Clinical Advisory Board.
- The strategic expansion solidifies eVisit's leadership in the telehealth landscape, empowering healthcare systems to deliver exceptional
Read More
FDA Clears AliveCor’s Heart Attack-Detecting AI Kardia 12L ECG System
What You Should Know:
- AliveCor, a leader in AI-powered cardiology, has received FDA clearance and launched a groundbreaking innovation – the Kardia™ 12L ECG System with KAI™ 12L AI technology.
- AliveCor's Kardia 12L ECG System signifies a major advancement in cardiac diagnostics. By combining cutting-edge AI technology with a portable and user-friendly design, the system empowers healthcare professionals to deliver faster, more accurate, and more accessible cardiac
Read More
Adonis Raises $31M to Expand AI-Powered Revenue Cycle Automation
What You Should Know:
- Adonis, a healthcare revenue intelligence and automation company raises $31M in Series B funding led by Point72 Private Investments, bringing Adonis’ total funding to $54M.
- With this new funding, Adonis plans to accelerate product innovation, expand its reach within health systems, and grow its team based in New York City. This latest investment round follows a successful Series A round of $17.3M led by General Catalyst just twelve months ago.
Read More
Merck Global Health Innovation Fund Invests in Qure.ai to Expand Lung Cancer Detection
What You Should Know:
- Merck Global Health Innovation Fund (MGHIF), a leader in healthcare impact investing, announced a strategic investment in Qure.ai, a prominent developer of artificial intelligence (AI) solutions for medical imaging.
- The strategic investment fuels Qure.ai's Series D funding round and propels their mission of expanding access to AI-powered imaging technology globally.
Expanding Reach and Capabilities
The funding will be directed towards two key
Read More
Proscia and Nucleai Partner to Integrate Predictive Biomarker Solutions
What You Should Know:
- Proscia, a leader in artificial intelligence (AI)-powered pathology solutions, and Nucleai, a leading spatial AI biomarker company, announced a strategic partnership today. This collaboration aims to revolutionize precision medicine by integrating Nucleai's advanced biomarker technology with Proscia's Concentriq® software platform.
- By harnessing the power of AI and digital pathology, this partnership offers the potential to fundamentally improve the
Read More
Children’s National Hospital Expands Use of Laudio Platform to Empower Nurse Educators and Combat Burnout
What You Should Know:
- Laudio, a leader in frontline leader solutions for healthcare systems, announced today the expansion of its partnership with Children's National Hospital, the premier pediatric health system in the Washington, D.C. area.
- The expansion brings nurse educators onto the Laudio platform, building upon the successful implementation with nurse managers in 2021.
Streamlining Workflows and Boosting Engagement
The Laudio platform offers a comprehensive
Read More
Black and Hispanic Patients Face Higher Liver Cancer ED Visits, Study Finds
What You Should Know:
- A new study by Inovalon, a leader in healthcare data analytics, sheds light on racial and socioeconomic disparities in emergency department (ED) visits for patients with hepatocellular carcinoma (HCC), the most common type of liver cancer.
- The study, conducted in collaboration with Genentech, a member of the Roche Group, and Thomas Jefferson University Hospital, highlights the significant impact of social determinants of health (SDOH) on access to
Read More
HHS Finalizes Rules to Penalize Healthcare Providers Engaging in Information Blocking
What You Should Know:
- The U.S. Department of Health and Human Services (HHS) announced a new final rule today aimed at preventing information blocking in healthcare.
- The final rule establishes disincentives for healthcare providers who engage in practices that interfere with a patient's access to their electronic health information (EHI).
What is Information Blocking?
Information blocking occurs when a healthcare provider knowingly and unreasonably interferes with the
Read More
Atropos Health Expands Evidence Network with 5 New Partners
What You Should Know:
- Atropos Health announced significant growth for its Atropos Evidence Network, adding new partners, a new customer, and a wider range of datasets.
- Atropos Health's expansion demonstrates its commitment to revolutionizing healthcare through real-world data and fostering a collaborative environment for evidence-based decision-making.
More Data, More Possibilities
The Atropos Evidence Network welcomes Forian and Syndesis Health, expanding the reach
Read More
